Please login (Members) to view content or
(Nonmembers) this article.
0
No votes yet
Letters to the Editor

Letters to The Editor

Lisa Schulmeister
Peter C. Pieslor
CJON 2003, 7(1), 12 DOI: 10.1188/03.CJON.12

In a recent “Clinical Q&A” titled “Handling and Disposal of Monoclonal Antibodies,” the author reviewed guidelines for your readers (Estes, 2002). The manufacturers are not correct in Table 1 on page 290. Zevalin® is manufactured by IDEC Pharmaceuticals Corporation in San Diego, CA. Rituxan® is comarketed by IDEC Pharmaceuticals Corporation and Genentech, Inc., in South San Francisco, CA.

Members Only

Access to this article is restricted. Please login to view the full article.

Not a current ONS Member or journal subscriber?
Join/Renew Membership or